Combination therapy with IL-2 and wild-type p53 expressed by Ad-vectors induces tumor regression in vivo without cytokine related toxicity. - Institut für Experimentelle Gentherapie und Tumorforschung

Pützer BM, Bramson JL, Addison CL, Muller WJ, Graham FL.

Combination therapy with IL-2 and wild-type p53 expressed by Ad-vectors induces tumor regression in vivo without cytokine related toxicity.

Cancer Gene Ther. 1997; 4:P137-P137 Suppl. S.